^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

IDO1 expression

i
Other names: IDO1, IDO, INDO, Indoleamine 2,3-dioxygenase 1
Entrez ID:
Related biomarkers:
Phase 1
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
03/11/2024
Initiation :
08/25/2014
Primary completion :
03/31/2016
Completion :
03/07/2025
IDO1
|
IDO1 expression
|
epacadostat (INCB024360)
Phase 2
UNC Lineberger Comprehensive Cancer Center
Completed
Last update posted :
11/15/2023
Initiation :
04/19/2017
Primary completion :
04/01/2021
Completion :
07/01/2023
LAG3 • HAVCR2 • CD27
|
IDO1 expression
|
Keytruda (pembrolizumab)
Phase 1
Merck Sharp & Dohme LLC
Completed
Last update posted :
08/19/2022
Initiation :
08/23/2016
Primary completion :
11/20/2020
Completion :
11/20/2020
EGFR • PD-L1 • ALK • IDO1
|
IDO1 expression
|
Keytruda (pembrolizumab) • cisplatin • carboplatin • albumin-bound paclitaxel • pemetrexed • epacadostat (INCB024360)
Phase 2
Cliniques universitaires Saint-Luc- Université ...
Unknown status
Last update posted :
01/10/2020
Initiation :
11/13/2019
Primary completion :
06/30/2022
Completion :
06/30/2022
CD8 • IDO1 • CD4
|
IDO1 expression
|
celecoxib oral
Phase 2
Cliniques universitaires Saint-Luc- Université ...
Unknown status
Last update posted :
07/12/2019
Initiation :
08/15/2019
Primary completion :
06/15/2021
Completion :
06/15/2021
BRAF • IDO1
|
BRAF mutation • IDO1 expression • IDO1 positive
|
Opdivo (nivolumab) • celecoxib oral
Phase 2
Fred Hutchinson Cancer Center
Completed
Last update posted :
06/08/2018
Initiation :
09/13/2013
Primary completion :
10/31/2016
Completion :
05/18/2017
BRAF • CD8 • IFNG • CTLA4 • IDO1 • CD4
|
BRAF V600E • BRAF V600 • CD8 expression • IDO1 expression
|
epacadostat (INCB024360)
Phase 1/2
University of Pittsburgh
Withdrawn
Last update posted :
09/20/2017
Initiation :
10/01/2016
Primary completion :
02/09/2017
Completion :
02/09/2017
PD-L1 • CD8 • IDO1
|
PD-L1 expression • IDO1 expression
|
Opdivo (nivolumab) • Yervoy (ipilimumab)
Phase 1
Radiotherapie
Completed
Last update posted :
01/10/2017
Initiation :
03/01/2015
Primary completion :
08/01/2016
Completion :
08/01/2016
IDO1 • FOXP3
|
IDO1 expression
|
Yervoy (ipilimumab)